Invention Grant
- Patent Title: Modulators of eukaryotic initiation factor 2B, compositions and methods
-
Application No.: US16637718Application Date: 2018-08-08
-
Publication No.: US11236100B2Publication Date: 2022-02-01
- Inventor: Robert A. Craig, II , Javier de Vicente Fidalgo , Anthony A. Estrada , Jianwen A. Feng , Brian M. Fox , Christopher R. H. Hale , Katrina W. Lexa , Maksim Osipov , Travis Remarchuk , Zachary K. Sweeney
- Applicant: Denali Therapeutics Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Denali Therapeutics Inc.
- Current Assignee: Denali Therapeutics Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- International Application: PCT/US2018/045868 WO 20180808
- International Announcement: WO2019/032743 WO 20190214
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07C235/22 ; C07C233/05 ; C07C217/52 ; C07C211/38 ; C07D207/27 ; C07D233/36 ; C07D233/42 ; C07D233/61 ; C07D233/64 ; C07D249/04 ; C07D249/08 ; C07D257/04 ; C07D261/04 ; C07D261/08 ; C07D263/32 ; C07D263/38 ; C07D263/56 ; C07D271/06 ; C07D271/10 ; C07D291/04 ; C07D401/12 ; C07D403/04 ; C07D403/12 ; C07D413/04 ; C07D413/06 ; C07D413/12 ; C07D417/04 ; C07D471/04 ; C07D487/04
Abstract:
The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.
Public/Granted literature
- US20210147435A1 COMPOUNDS, COMPOSITIONS AND METHODS Public/Granted day:2021-05-20
Information query
